Users Coming Off Weight-Loss Medications Put On Pounds Far More Rapidly Compared to Those on Conventional Diets

A recent study reveals that patients who stop using popular weight-loss injections like semaglutide or tirzepatide may regain lost weight much more quickly than those who stop traditional lifestyle regimens.

Published data in a prominent health publication shows that while overweight people frequently drop a large proportion of their total mass while on the medication, the mass comes back at an estimated rate of 0.8 kg per month after stopping.

"Users purchasing such drugs must be aware of the danger of quick weight regain when the treatment concludes," stated lead investigator Dr. Susan Jebb.

Such speed of regain means a reversion to pre-treatment weight in about a year and a half.

Comparing Treatments

The research, which looked at 37 of trials involving thousands of participants, compared the outcomes of these new drugs with conventional dieting.

The team point out that people who lose weight through lifestyle changes alone usually have a more gradual creep back—perhaps 100 grams monthly—after stopping.

Explaining the Rapid Regain

Nutrition scientists suggest the way of the injections explains the amplified rebound.

These medications copy a body's own chemical called GLP-1, which moderates hunger.

"Sustained high doses of the hormone levels far above than normal could lead to the body to produce less of its endogenous GLP-1, and could reduce sensitivity to its actions," said Dr. Adam Collins, a dietetics researcher.

"Discontinuation of this GLP-1 'fix' leads to appetite is uncontrolled, making excessive eating a significant risk."

A Chronic Condition?

Health authorities recommend the jabs for individuals with weight-linked medical conditions, accompanied by prescribed lifestyle changes.

Many experts argue that, considering the significant potential of weight regain, the treatment is often life-long.

This view is echoed by pharmaceutical companies, who state that the findings "emphasize the persistent nature of obesity," akin to managing diseases like high blood pressure.

User Testimonies

Users who have discontinued the jabs report a sudden return of appetite.

"It felt as if a trigger flipping and I was suddenly extremely hungry," said one woman.

The struggle is compounded if users have not adopted sustainable lifestyle or habit modifications during therapy.

Growing Adoption

Figures suggest that a significant number of adults in the UK have tried these injections in the last 12 months, with interest continuing to grow.

• Use is more common among women compared to men.
• The 40s and 50s age group shows the highest level of interest.
• Many access the drugs through private prescriptions rather than public health services.

In conclusion, experts caution that while GLP-1 drugs are potent tools for weight loss, they are not a standalone solution and maintained weight loss relies on combined lifestyle support.